Showing results (111-120 of 146) with videos related to
Sort By:
Pageof 15
Investigational New Drugs|December 1, 1988
In vivo antitumor activity of sparsomycin and its analogues in eight murine tumor modelsZ Zylicz, D J Wagener, H van Rennes, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1993
Phase II study of sequential high-dose methotrexate (MTX) and 5-fluorouracil (F) alternated with epirubicin (E) and cisplatin (P) [FEMTX-P] in advanced gastric cancerE J Roelofs, D J Wagener, T Conroy, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Phase II study of nimustine in metastatic soft tissue sarcoma. European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma GroupD J Wagener, R Somers, A Santoro, et al.Anticancer Research|March 1, 1996
Immunohistochemical determination of glutathione S-transferases in gastric carcinomas and in adjacent normal gastric epitheliumD L Schipper, M J Wagenmans, U Van Haelst, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1991
Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative GroupJ A Wils, H O Klein, D J Wagener, et al.Anticancer Research|July 1, 1989
Studies on retinotoxic potential of a novel antitumor antibiotic--sparsomycin--in ratsZ Zylicz, W J De Grip, D J Wagener, et al.Journal of Clinical Periodontology|March 1, 1993
Comparison between mechanical cleaning and an antimicrobial rinse for the treatment and prevention of interdental gingivitisJ G Caton, T M Blieden, R A Lowenguth, et al.Nuklearmedizin. Nuclear Medicine|October 11, 2013
Biodistribution and dosimetry of 195mPt-cisplatin in normal volunteers. Imaging agent for single photon emission computed tomographyM Sathekge, J Wagener, S V Smith, et al.Cancer Chemotherapy and Pharmacology|January 1, 1993
Correlation of the in vitro cytotoxicity of ethyldeshydroxysparsomycin and cisplatin with the in vivo antitumour activity in murine L1210 leukaemia and two resistant L1210 subclonesH P Hofs, D J Wagener, V de Valk-Bakker, et al.Anticancer Research|January 1, 1992
Potentiation of cisplatin antitumour activity by Ethyldeshydroxy-Sparsomycin in L1210 leukemiaH P Hofs, D J Wagener, V De Valk-Bakker, et al.Pageof 15